Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation. (arXiv:2309.07939v1 [physics.bio-ph]) http://arxiv.org/abs/2309.07939